ArticleThe oncologist2022

The Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy.

Chao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.